GCM
INSP icon

Glaxis Capital Management’s Inspire Medical Systems INSP Stock Holding History

Glaxis Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,500
Closed -$642K – 26
2022
Q1 		$642K Buy
+2,500
New +$571K 0.91% 18

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Glaxis Capital Management's INSP Position: Q2 2022 in Review

Glaxis Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2022, closing a stake of 2,500 shares — an estimated $642K sold.

Glaxis Capital Management first reported a position in INSP in Q1 2022 and held it in 1 quarter. The position peaked at $642K in Q1 2022. 286 funds tracked by Wall St. Rank hold INSP as of Q2 2022.

  • Glaxis Capital Management reported no remaining Inspire Medical Systems position as of Q2 2022 after selling out during the quarter.
  • Glaxis Capital Management sold 2,500 Inspire Medical Systems shares in Q2 2022, an estimated $642K.
  • Glaxis Capital Management first reported a position in Inspire Medical Systems in Q1 2022 and held it in 1 quarter.
  • Glaxis Capital Management's Inspire Medical Systems position peaked at $642K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2022.

Based on Glaxis Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.